Role of macrophage in nanomedicine-based disease treatment

References

• Adegbola SO, Sahnan K, Warusavitarne J, et al. (2018). Anti-TNF therapy in Crohn’s disease. Int J Mol Sci 19:2244.
   PubMed Web of Science ®Google Scholar
• Ahsan F, Rivas IP, Khan MA, et al. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers–liposomes and microspheres–on the phagocytosis by macrophages. J Control Release 79:29–40.
   PubMed Web of Science ®Google Scholar
• Amash A, Wang L, Wang Y, et al. (2016). CD44 antibody inhibition of macrophage phagocytosis targets Fcγ receptor- and complement receptor 3-dependent mechanisms. J Immunol 196:3331–40.
   PubMed Web of Science ®Google Scholar
• An L, Wang Y, Lin J, et al. (2019). Macrophages-mediated delivery of small gold nanorods for tumor hypoxia photoacoustic imaging and enhanced photothermal therapy. ACS Appl Mater Interfaces 11:15251–61.
   PubMed Web of Science ®Google Scholar
• Ayer M, Klok H-A. (2017). Cell-mediated delivery of synthetic nano- and microparticles. J Control Release 259:92–104.
   PubMed Web of Science ®Google Scholar
• Baroni S, Ruggiero MR, Bitonto V, et al. (2020). In vivo assessment of tumour associated macrophages in murine melanoma obtained by low-field relaxometry in the presence of iron oxide particles. Biomaterials 236:119805.
   PubMed Web of Science ®Google Scholar
• Beck A, Goetsch L, Dumontet C, et al. (2017). Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov 16:315–37.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33:941–51.
   PubMed Web of Science ®Google Scholar
• Brown GD, Taylor PR, Reid DM, et al. (2002). Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 196:407–12.
   PubMed Web of Science ®Google Scholar
• Buisson A, Bringer M-A, Barnich N, et al. (2016). Macrophages versus Escherichia coli: a decisive fight in Crohn’s disease. Inflamm Bowel Dis 22:2943–55.
   PubMed Web of Science ®Google Scholar
• Chalouni C, Doll S. (2018). Fate of antibody-drug conjugates in cancer cells. J Exp Clin Cancer Res 37:20.
   PubMed Web of Science ®Google Scholar
• Chao Y, Karmali PP, Mukthavaram R, et al. (2013). Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI. ACS Nano 7:4289–98.
   PubMed Web of Science ®Google Scholar
• Chari RV. (2008). Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res 41:98–107.
   PubMed Web of Science ®Google Scholar
• Chau CH, Steeg PS, Figg WD. (2019). Antibody-drug conjugates for cancer. Lancet 394:793–804.
   PubMed Web of Science ®Google Scholar
• Chen BK, Chiu H-F, Yang C-Y. (2016). Statins are associated with a reduced risk of brain cancer: a population-based case-control study. Medicine 95:e3392.
   PubMed Web of Science ®Google Scholar
• Chen M, Daddy J C KA, Xiao Y, et al. (2017). Advanced nanomedicine for rheumatoid arthritis treatment: focus on active targeting. Expert Opin Drug Deliv 14:1141–4.
   PubMed Web of Science ®Google Scholar
• Chen W, Quan Y, Fan S, et al. (2020). Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression. Cancer Lett 475:119–28.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu Y, Wen Y, et al. (2019). A photothermal-triggered nitric oxide nanogenerator combined with siRNA for precise therapy of osteoarthritis by suppressing macrophage inflammation. Nanoscale 11:6693–709.
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Du W, et al. (2019). Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci 26:78.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhang R, Li C, et al. (2018). A targeting nanotherapy for abdominal aortic aneurysms. J Am Coll Cardiol 72:2591–605.
   PubMed Web of Science ®Google Scholar
• Cheng L, Wang Y, Huang L. (2017). Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node. Mol Ther 25:1665–75.
   PubMed Web of Science ®Google Scholar
• Chiu H-T, Su C-K, Sun Y-C, et al. (2017). Albumin-gold nanorod nanoplatform for cell-mediated tumoritropic delivery with homogenous chemodrug distribution and enhanced retention ability. Theranostics 7:3034–52.
   PubMed Web of Science ®Google Scholar
• Choi M-R, Stanton-Maxey KJ, Stanley JK, et al. (2007). A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 7:3759–65.
   PubMed Web of Science ®Google Scholar
• Choo YW, Kang M, Kim HY, et al. (2018). M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors. ACS Nano 12:8977–93.
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Théry C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–89.
   PubMed Web of Science ®Google Scholar
• Conde J, Bao C, Tan Y, et al. (2015). Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells. Adv Funct Mater 25:4183–94.
   PubMed Web of Science ®Google Scholar
• Crielaard BJ, Lammers T, Schiffelers RM, et al. (2012). Drug targeting systems for inflammatory disease: one for all, all for one. J Control Release 161:225–34.
   PubMed Web of Science ®Google Scholar
• Cullis J, Siolas D, Avanzi A, et al. (2017). Macropinocytosis of nab-paclitaxel drives macrophage activation in pancreatic cancer. Cancer Immunol Res 5:182–90.
   PubMed Web of Science ®Google Scholar
• Dancy JG, Wadajkar AS, Connolly NP, et al. (2020). Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer. Sci Adv 6:eaax3931.
   PubMed Web of Science ®Google Scholar
• De Pablo-Fernández E, Courtney R, Warner TT, et al. (2018). A histologic study of the Circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy. JAMA Neurol 75:1008–12.
   PubMed Web of Science ®Google Scholar
• Dehne N, Mora J, Namgaladze D, et al. (2017). Cancer cell and macrophage cross-talk in the tumor microenvironment. Curr Opin Pharmacol 35:12–9.
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Ruffell B. (2019). Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19:369–82.
   PubMed Web of Science ®Google Scholar
• Duncan R, Gaspar R. (2011). Nanomedicine(s) under the microscope. Mol Pharm 8:2101–41.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group. (2011). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–16.
   PubMed Web of Science ®Google Scholar
• Eisinger S, Sarhan D, Boura VF, et al. (2020). Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells. Proc Natl Acad Sci USA 117:32005–16.
   PubMed Web of Science ®Google Scholar
• Emanuel EJ, Wendler D, Grady C. (2000). What makes clinical research ethical? JAMA 283:2701–11.
   PubMed Web of Science ®Google Scholar
• Etzerodt A, Tsalkitzi K, Maniecki M, et al. (2019). Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression . J Exp Med 216:2394–411.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. (2011). The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–51.
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa, T, Maeda H, eds. (2003). Factors and mechanism of “EPR” effect and the enhanced antitumor effects of macromolecular drugs including SMANCS. In: Polymer drugs in the clinical stage: advantages and prospects. Boston (MA): Springer, 29–49.
   Google Scholar
• Figueiredo P, Lepland A, Scodeller P, et al. (2020). Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy. Acta Biomater. S1742-7061(20)30561-4.
   Web of Science ®Google Scholar
• Fisher EA, Feig JE, Hewing B, et al. (2012). High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 32:2813–20.
   PubMed Web of Science ®Google Scholar
• Fleige G, Nolte C, Synowitz M, et al. (2001). Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 3:489–99.
   PubMed Web of Science ®Google Scholar
• Flores AM, Hosseini-Nassab N, Jarr K-U, et al. (2020). Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat Nanotechnol 15:154–61.
   PubMed Web of Science ®Google Scholar
• Flühmann B, Ntai I, Borchard G, et al. (2019). Nanomedicines: the magic bullets reaching their target? Eur J Pharm Sci 128:73–80.
   PubMed Web of Science ®Google Scholar
• Forest V, Leclerc L, Hochepied J-F, et al. (2017). Impact of cerium oxide nanoparticles shape on their in vitro cellular toxicity. Toxicol in Vitro 38:136–41.
   PubMed Web of Science ®Google Scholar
• Frambach SJCM, de Haas R, Smeitink JAM, et al. (2020). Brothers in arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment. Pharmacol Rev 72:152–90.
   PubMed Web of Science ®Google Scholar
• Fukui S, Iwamoto N, Takatani A, et al. (2018). M1 and M2 monocytes in rheumatoid arthritis: a contribution of imbalance of M1/M2 monocytes to osteoclastogenesis. Front Immunol 8:1958.
   PubMed Web of Science ®Google Scholar
• Fusser M, Øverbye A, Pandya AD, et al. (2019). Cabazitaxel-loaded poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. J Control Release 293:183–92.
   PubMed Web of Science ®Google Scholar
• Gabizon AA, Patil Y, La-Beck NM. (2016). New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy. Drug Resist Updat 29:90–106.
   PubMed Web of Science ®Google Scholar
• Gaist D, Andersen L, Hallas J, et al. (2013). Use of statins and risk of glioma: a nationwide case-control study in Denmark. Br J Cancer 108:715–20.
   PubMed Web of Science ®Google Scholar
• Ganbold T, Baigude H. (2018). Design of mannose-functionalized curdlan nanoparticles for macrophage-targeted siRNA delivery. ACS Appl Mater Interfaces 10:14463–74.
   PubMed Web of Science ®Google Scholar
• Gao F, Zhang C, Qiu W-X, et al. (2018). PD-1 blockade for improving the antitumor efficiency of polymer–doxorubicin nanoprodrug. Small 14:1802403.
   Web of Science ®Google Scholar
• Go G, Lee J, Choi D-S, et al. (2019). Extracellular vesicle-mimetic ghost nanovesicles for delivering anti-inflammatory drugs to mitigate gram-negative bacterial outer membrane vesicle-induced systemic inflammatory response syndrome. Adv Healthc Mater 8:e1801082.
   PubMed Web of Science ®Google Scholar
• Guo M, et al. (2019). Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion. Sci Transl Med 11:eaat5690.
   PubMed Web of Science ®Google Scholar
• Hagimori M, Chinda Y, Suga T, et al. (2018). Synthesis of high functionality and quality mannose-grafted lipids to produce macrophage-targeted liposomes. Eur J Pharm Sci 123:153–61.
   PubMed Web of Science ®Google Scholar
• Halley PD, Lucas CR, McWilliams EM, et al. (2016). Daunorubicin-loaded DNA origami nanostructures circumvent drug-resistance mechanisms in a leukemia model. Small 12:308–20.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Zhao Y, Li S, et al. (2011). Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells. Nanomedicine 6:1215–30.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, et al. (2010). Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657–66.
   PubMed Web of Science ®Google Scholar
• He J, Yang Y, Zhou X, et al. (2020). Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake in macrophage/foam cells. J Mater Chem B 8:1496–506.
   PubMed Web of Science ®Google Scholar
• Hickey WF. (1999). Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 11:125–37.
   PubMed Web of Science ®Google Scholar
• Holder B, Jones T, Sancho Shimizu V, et al. (2016). Macrophage exosomes induce placental inflammatory cytokines: a novel mode of maternal-placental messaging. Traffic 17:168–78.
   PubMed Web of Science ®Google Scholar
• Howard D, Garcia-Parra J, Healey GD, et al. (2016). Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. Interface Focus 6:20160054.
   PubMed Web of Science ®Google Scholar
• Hristodorov D, Mladenov R, von Felbert V, et al. (2015). Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies. MAbs 7:853–62.
   PubMed Web of Science ®Google Scholar
• Huang Y, Guo J, Gui S. (2018). Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis. Eur J Pharm Sci 125:232–43.
   PubMed Web of Science ®Google Scholar
• Huang Z, Sun X, Liu X, et al. (2018). Macrophages as an active tumour-targeting carrier of SN38-nanoparticles for cancer therapy. J Drug Target 26:458–65.
   PubMed Web of Science ®Google Scholar
• Hurdayal R, Nieuwenhuizen NE, Khutlang R, et al. (2019). Inflammatory dendritic cells, regulated by IL-4 receptor alpha signaling, control replication, and dissemination of leishmania major in mice. Front Cell Infect Microbiol 9:479.
   PubMed Web of Science ®Google Scholar
• Hussaarts L, Mühlebach S, Shah VP, et al. (2017). Equivalence of complex drug products: advances in and challenges for current regulatory frameworks. Ann NY Acad Sci 1407:39–49.
   PubMed Web of Science ®Google Scholar
• Jain S, Tran T-H, Amiji M. (2015). Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis. Biomaterials 61:162–77.
   PubMed Web of Science ®Google Scholar
• Jasinski DL, Li H, Guo P. (2018). The effect of size and shape of RNA nanoparticles on biodistribution. Mol Ther 26:784–92.
   PubMed Web of Science ®Google Scholar
• Jiang P, Gao W, Ma T, et al. (2019). CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages. Theranostics 9:2950–66.
   PubMed Web of Science ®Google Scholar
• Jin H, He Y, Zhao P, et al. (2019). Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery. Theranostics 9:265–78.
   PubMed Web of Science ®Google Scholar
• Kalinec GM, Gao L, Cohn W, et al. (2019). Extracellular vesicles from auditory cells as nanocarriers for anti-inflammatory drugs and pro-resolving mediators. Front Cell Neurosci 13:530.
   PubMed Web of Science ®Google Scholar
• Keewan Ea, Naser SA. (2020). The role of notch signaling in macrophages during inflammation and infection: implication in rheumatoid arthritis? Cells 9:111.
   PubMed Web of Science ®Google Scholar
• Khawar IA, Kim JH, Kuh H-J. (2015). Improving drug delivery to solid tumors: priming the tumor microenvironment. J Control Release 201:78–89.
   PubMed Web of Science ®Google Scholar
• Khera E, Thurber GM. (2018). Pharmacokinetic and immunological considerations for expanding the therapeutic window of next-generation antibody-drug conjugates. BioDrugs 32:465–80.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim HY, Song SY, et al. (2019). Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano 13:3206–17.
   PubMed Web of Science ®Google Scholar
• Kriegel C, Amiji M. (2011). Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease. J Control Release 150:77–86.
   PubMed Web of Science ®Google Scholar
• Kumar CSSR, Mohammad F. (2011). Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev 63:789–808.
   PubMed Web of Science ®Google Scholar
• Kurahara H, Shinchi H, Mataki Y, et al. (2011). Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 167:e211–9.
   PubMed Web of Science ®Google Scholar
• Lameijer MA, Tang J, Nahrendorf M, et al. (2013). Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. Expert Rev Mol Diagn 13:567–80.
   PubMed Web of Science ®Google Scholar
• Lawrence T, Natoli G. (2011). Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750–61.
   PubMed Web of Science ®Google Scholar
• Leidal AM, Huang HH, Marsh T, et al. (2020). The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol 22:187–99.
   PubMed Web of Science ®Google Scholar
• Li F, Ulrich M, Jonas M, et al. (2017). Tumor-associated macrophages can contribute to antitumor activity through FcγR-mediated processing of antibody-drug conjugates. Mol Cancer Ther 16:1347–54.
   PubMed Web of Science ®Google Scholar
• Li R, He Y, Zhu Y, et al. (2019). Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles. Nano Lett 19:124–34.
   PubMed Web of Science ®Google Scholar
• Li X, Li C, Zhang L, et al. (2020). The significance of exosomes in the development and treatment of hepatocellular carcinoma. Mol Cancer 19:1.
   PubMed Web of Science ®Google Scholar
• Li X, Zhu M, Penfold ME, et al. (2014). Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue. Circulation 129:1244–53.
   PubMed Web of Science ®Google Scholar
• Li Z, Sun L, Zhang Y, et al. (2016). Shape effect of glyco-nanoparticles on macrophage cellular uptake and immune response. ACS Macro Lett 5:1059–64.
   PubMed Web of Science ®Google Scholar
• Libby P. (2002). Inflammation in atherosclerosis. Nature 420:868–74.
   PubMed Web of Science ®Google Scholar
• Liu X, Jiang J, Chan R, et al. (2019). Improved efficacy and reduced toxicity using a custom-designed irinotecan-delivering silicasome for orthotopic colon cancer. ACS Nano 13:38–53.
   PubMed Web of Science ®Google Scholar
• Liu X, Tang I, Wainberg ZA, et al. (2020). Safety considerations of cancer nanomedicine-a key step toward translation. Small 16:e2000673.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wen Y, Chen X, et al. (2019). Inflammation-responsive functional Ru nanoparticles combining a tumor-associated macrophage repolarization strategy with phototherapy for colorectal cancer therapy. J Mater Chem B 7:6210–23.
   PubMed Web of Science ®Google Scholar
• Locati M, Curtale G, Mantovani A. (2020). Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol 15:123–47.
   PubMed Web of Science ®Google Scholar
• Ma J, Liu R, Wang X, et al. (2015). Crucial role of lateral size for graphene oxide in activating macrophages and stimulating pro-inflammatory responses in cells and animals. ACS Nano 9:10498–515.
   PubMed Web of Science ®Google Scholar
• Madsen SJ, Baek S-K, Makkouk AR, et al. (2012). Macrophages as cell-based delivery systems for nanoshells in photothermal therapy. Ann Biomed Eng 40:507–15.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, et al. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677–86.
   PubMed Web of Science ®Google Scholar
• Maurizi L, Papa A-L, Dumont L, et al. (2015). Influence of surface charge and polymer coating on internalization and biodistribution of polyethylene glycol-modified iron oxide nanoparticles. J Biomed Nanotechnol 11:126–36.
   PubMed Web of Science ®Google Scholar
• Mause SF, Weber C. (2010). Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107:1047–57.
   PubMed Web of Science ®Google Scholar
• Mellman I, Coukos G, Dranoff G. (2011). Cancer immunotherapy comes of age. Nature 480:480–9.
   PubMed Web of Science ®Google Scholar
• Miao L, Lin CM, Huang L. (2015). Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. J Control Release 219:192–204.
   PubMed Web of Science ®Google Scholar
• Min Y, Caster JM, Eblan MJ, et al. (2015). Clinical translation of nanomedicine. Chem Rev 115:11147–90.
   PubMed Web of Science ®Google Scholar
• Mo X, Zheng Z, He Y, et al. (2018). Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide. J Control Release 287:12–23.
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Li Y, Abebe DG, et al. (2016). Folate receptor targeted three-layered micelles and hydrogels for gene delivery to activated macrophages. J Control Release 244:269–79.
   PubMed Web of Science ®Google Scholar
• Moore KJ, Tabas I. (2011). Macrophages in the pathogenesis of atherosclerosis. Cell 145:341–55.
   PubMed Web of Science ®Google Scholar
• Mosser DM, Edwards JP. (2008). Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–69.
   PubMed Web of Science ®Google Scholar
• Moura CC, Segundo MA, Neves J. d, et al. (2014). Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application. Int J Nanomedicine 9:4911–22.
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. (2011a). Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 89:557–63.
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. (2011b). Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723–37.
   PubMed Web of Science ®Google Scholar
• Na YR, Stakenborg M, Seok SH, et al. (2019). Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol 16:531–43.
   PubMed Web of Science ®Google Scholar
• Nahrendorf M, Swirski FK. (2016). Abandoning M1/M2 for a network model of macrophage function. Circ Res 119:414–7.
   PubMed Web of Science ®Google Scholar
• Nally FK, Santi CD, McCoy CE. (2019). Nanomodulation of macrophages in multiple sclerosis. Cells 8:543.
   PubMed Web of Science ®Google Scholar
• Nathan C, Ding A. (2010). Nonresolving inflammation. Cell 140:871–82.
   PubMed Web of Science ®Google Scholar
• Ngambenjawong C, Gustafson HH, Pun SH. (2017). Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 114:206–21.
   PubMed Web of Science ®Google Scholar
• Nguyen M-A, Wyatt H, Susser L, et al. (2019). Delivery of MicroRNAs by chitosan nanoparticles to functionally alter macrophage cholesterol efflux in vitro and in vivo. ACS Nano 13:6491–505.
   PubMed Web of Science ®Google Scholar
• Ni R, Song G, Fu X, et al. (2020). Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway. Biomaterials 232:119730.
   PubMed Web of Science ®Google Scholar
• Öhman T, Teirilä L, Lahesmaa-Korpinen A-M, et al. (2014). Dectin-1 pathway activates robust autophagy-dependent unconventional protein secretion in human macrophages. J Immunol 192:5952–62.
   PubMed Web of Science ®Google Scholar
• Orihuela R, McPherson CA, Harry GJ. (2016). Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 173:649–65.
   PubMed Web of Science ®Google Scholar
• Ouimet M, Barrett TJ, Fisher EA. (2019). HDL and reverse cholesterol transport. Circ Res 124:1505–18.
   PubMed Web of Science ®Google Scholar
• Ovais M, Guo M, Chen C. (2019). Tailoring nanomaterials for targeting tumor-associated macrophages. Adv Mater 31:1808303.
   PubMed Web of Science ®Google Scholar
• Pang L, Zhang C, Qin J, et al. (2017). A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles. Drug Deliv 24:83–91.
   PubMed Web of Science ®Google Scholar
• Patel S, Kim J, Herrera M, et al. (2019). Brief update on endocytosis of nanomedicines. Adv Drug Deliv Rev 144:90–111.
   PubMed Web of Science ®Google Scholar
• Pelaz B, Alexiou C, Alvarez-Puebla RA, et al. (2017). Diverse applications of nanomedicine. ACS Nano 11:2313–81.
   PubMed Web of Science ®Google Scholar
• Pollard JW. (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78.
   PubMed Web of Science ®Google Scholar
• Prabhakar U, Maeda H, Jain RK, et al. (2013). Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 73:2412–7.
   PubMed Web of Science ®Google Scholar
• Qadri M, Almadani S, Jay GD, et al. (2018). Role of CD44 in regulating TLR2 activation of human macrophages and downstream expression of proinflammatory cytokines. J Immunol 200:758–67.
   PubMed Web of Science ®Google Scholar
• Qi R, Majoros I, Misra AC, et al. (2015). Folate receptor-targeted dendrimer-methotrexate conjugate for inflammatory arthritis. j Biomed Nanotechnol 11:1431–41.
   PubMed Web of Science ®Google Scholar
• Qian Y, Qiao S, Dai Y, et al. (2017). Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages. ACS Nano 11:9536–49.
   PubMed Web of Science ®Google Scholar
• Qiang L, Cai Z, Jiang W, et al. (2019). A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy. J Nanobiotechnology 17:83.
   PubMed Web of Science ®Google Scholar
• Ran L, Tan X, Li Y, et al. (2016). Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials 89:56–66.
   PubMed Web of Science ®Google Scholar
• Rayamajhi S, Nguyen TDT, Marasini R, et al. (2019). Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery. Acta Biomater 94:482–94.
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Suarez Y, Davalos A, et al. (2010). MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328:1570–3.
   PubMed Web of Science ®Google Scholar
• Regdon Z, Robaszkiewicz A, Kovács K, et al. (2019). LPS protects macrophages from AIF-independent parthanatos by downregulation of PARP1 expression, induction of SOD2 expression, and a metabolic shift to aerobic glycolysis. Free Radic Biol Med 131:184–96.
   PubMed Web of Science ®Google Scholar
• Roberts AB, Sporn MB, Assoian RK, et al. (1986). Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–71.
   PubMed Web of Science ®Google Scholar
• Ruan G-X, Chen Y-Z, Yao X-L, et al. (2014). Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering. Acta Biomater 10:1847–55.
   PubMed Web of Science ®Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. (2010). Endocytosis of nanomedicines. J Control Release 145:182–95.
   PubMed Web of Science ®Google Scholar
• Scali E, Mignogna C, Di Vito A, et al. (2016). Inflammation and macrophage polarization in cutaneous melanoma: histopathological and immunohistochemical study. Int J Immunopathol Pharmacol 29:715–9.
   PubMed Web of Science ®Google Scholar
• Scodeller P, Simón-Gracia L, Kopanchuk S, et al. (2017). Precision targeting of tumor macrophages with a CD206 binding peptide. Sci Rep 7:14655.
   PubMed Web of Science ®Google Scholar
• Senokuchi T, Matsumura T, Sakai M, et al. (2005). Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway. J Biol Chem 280:6627–33.
   PubMed Web of Science ®Google Scholar
• Sethi V, Rubinstein I, Kuzmis A, et al. (2013). Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis. Mol Pharm 10:728–738.,
   PubMedGoogle Scholar
• Sevic I, Spinelli FM, Cantero MJ, et al. (2019). The role of the tumor microenvironment in the development and progression of hepatocellular carcinoma. In: Tirnitz-Parker JEE, ed. Hepatocellular carcinoma. Brisbane (Australia): Codon Publication.
   Google Scholar
• Singh A, Talekar M, Raikar A, et al. (2014). Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases. J Control Release 190:515–30.
   PubMed Web of Science ®Google Scholar
• Singh R, Mishra MK, Aggarwal H. (2017). Inflammation, immunity, and cancer. Mediators Inflamm 2017:6027305.
   PubMed Web of Science ®Google Scholar
• Staudacher AH, Liapis V, Tieu W, et al. (2020). Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody. J Control Release 327:779–87.
   PubMed Web of Science ®Google Scholar
• Stein M, Keshav S, Harris N, et al. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176:287–92.
   PubMed Web of Science ®Google Scholar
• Steinbach EC, Plevy SE. (2014). The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis 20:166–75.
   PubMed Web of Science ®Google Scholar
• Stremersch S, De Smedt SC, Raemdonck K. (2016). Therapeutic and diagnostic applications of extracellular vesicles. J Control Release 244:167–83.
   PubMed Web of Science ®Google Scholar
• Su Z, Xiao Z, Wang Y, et al. (2020). Codelivery of anti-PD-1 antibody and paclitaxel with matrix metalloproteinase and pH dual-sensitive micelles for enhanced tumor chemoimmunotherapy. Small 16:1906832.
   Web of Science ®Google Scholar
• Tang J, Lobatto ME, Hassing L, et al. (2015). Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci Adv 1:e1400223.
   PubMed Web of Science ®Google Scholar
• Tang T-T, Lv L-L, Wang B, et al. (2019). Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone: an efficient therapeutic strategy against renal inflammation and fibrosis. Theranostics 9:4740–55.
   PubMed Web of Science ®Google Scholar
• Tariq M, Zhang J, Liang G, et al. (2017). Macrophage polarization: anti-cancer strategies to target tumor-associated macrophage in breast cancer. J Cell Biochem 118:2484–501.
   PubMed Web of Science ®Google Scholar
• Thakor AS, Jokerst J, Zavaleta C, et al. (2011). Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett 11:4029–36.
   PubMed Web of Science ®Google Scholar
• Thepen T, van Vuuren AJ, Kiekens RC, et al. (2000). Resolution of cutaneous inflammation after local elimination of macrophages. Nat Biotechnol 18:48–51.
   PubMed Web of Science ®Google Scholar
• Thomas TP, Goonewardena SN, Majoros IJ, et al. (2011). Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheum 63:2671–80.
   PubMed Web of Science ®Google Scholar
• Tiwari M, Kumar A, Sinha RA, et al. (2006). Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress. Carcinogenesis 27:2047–58.
   PubMed Web of Science ®Google Scholar
• Tong H-I, Kang W, Shi Y, et al. (2016). Physiological function and inflamed-brain migration of mouse monocyte-derived macrophages following cellular uptake of superparamagnetic iron oxide nanoparticles-Implication of macrophage-based drug delivery into the central nervous system. Int J Pharm 505:271–82.
   PubMed Web of Science ®Google Scholar
• Tran T-H, Rastogi R, Shelke J, et al. (2015). Modulation of macrophage functional polarity towards anti-inflammatory phenotype with plasmid DNA Delivery in CD44 targeting hyaluronic acid nanoparticles. Sci Rep 5:16632.
   PubMed Web of Science ®Google Scholar
• Ullah S, Seidel K, Türkkan S, et al. (2019). Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model. J Control Release 294:327–36.
   PubMed Web of Science ®Google Scholar
• van der V. (2010). Reverse cholesterol transport: from classical view to new insights. World J Gastroenterol 16:5908–15.
   PubMed Web of Science ®Google Scholar
• van Niel G, D'Angelo G, Raposo G. (2018). Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19:213–28.
   PubMed Web of Science ®Google Scholar
• Varghese B, Vlashi E, Xia W, et al. (2014). Folate receptor-β in activated macrophages: ligand binding and receptor recycling kinetics. Mol Pharmaceutics 11:3609–16.
   PubMed Web of Science ®Google Scholar
• Wagle N, Emery C, Berger MF, et al. (2011). Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol 29:3085–96.
   PubMed Web of Science ®Google Scholar
• Wang P, Wang H, Huang Q, et al. (2019). Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation. Theranostics 9:1714–27.
   PubMed Web of Science ®Google Scholar
• Wang T, Liu H, Lian G, et al. (2017). HIF1α-induced glycolysis metabolism is essential to the activation of inflammatory macrophages. Mediators Inflamm 2017:9029327.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhang J, Hou T, et al. (2019). Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy. Nanoscale 11:13934–46.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Y, Luehmann H, et al. (2012). Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging. ACS Nano 6:5880–8.
   PubMed Web of Science ®Google Scholar
• Wei AH, Tiong IS. (2017). Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML. Blood 130:2469–74.
   PubMed Web of Science ®Google Scholar
• Wu G, Zhang J, Zhao Q, et al. (2020). Molecularly engineered macrophage-derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment. Angew Chem Int Ed Engl 59:4068–74.
   PubMed Web of Science ®Google Scholar
• Wynn TA, Chawla A, Pollard JW. (2013). Macrophage biology in development, homeostasis and disease. Nature 496:445–55.
   PubMed Web of Science ®Google Scholar
• Xiao B, Laroui H, Ayyadurai S, et al. (2013). Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy. Biomaterials 34:7471–82.
   PubMed Web of Science ®Google Scholar
• Xiao B, Merlin D. (2012). Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert Opin Drug Deliv 9:1393–407.
   PubMed Web of Science ®Google Scholar
• Xiao S, Tang Y, Lv Z, et al. (2019). Nanomedicine - advantages for their use in rheumatoid arthritis theranostics. J Control Release 316:302–16.
   PubMed Web of Science ®Google Scholar
• Xie J, Huang Z, Yu X, et al. (2019). Clinical implications of macrophage dysfunction in the development of osteoarthritis of the knee. Cytokine Growth Factor Rev 46:36–44.
   PubMed Web of Science ®Google Scholar
• Xu F, Yuan Y, Shan X, et al. (2009). Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges. Int J Pharm 377:199–206.
   PubMed Web of Science ®Google Scholar
• Xu X, Ho W, Zhang X, et al. (2015). Cancer nanomedicine: from targeted delivery to combination therapy. Trends Mol Med 21:223–32.
   PubMed Web of Science ®Google Scholar
• Xue J, Schmidt SV, Sander J, et al. (2014). Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40:274–88.
   PubMed Web of Science ®Google Scholar
• Yang Y, Guo L, Wang Z, et al. (2021). Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization. Biomaterials 264:120390.
   PubMed Web of Science ®Google Scholar
• Yang Z, Sun Z, Ren Y, et al. (2019). Advances in nanomaterials for use in photothermal and photodynamic therapeutics (review). Mol Med Rep 20:5–15.
   PubMed Web of Science ®Google Scholar
• Ye Z, Zhang T, He W, et al. (2018). Methotrexate-loaded extracellular vesicles functionalized with therapeutic and targeted peptides for the treatment of glioblastoma multiforme. ACS Appl Mater Interfaces 10:12341–50.
   PubMed Web of Science ®Google Scholar
• Yin M, Li X, Tan S, et al. (2016). Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest 126:4157–73.
   PubMed Web of Science ®Google Scholar
• Yu X, Guo C, Fisher PB, et al. (2015). Scavenger receptors: emerging roles in cancer biology and immunology. Adv Cancer Res 128:309–64.
   PubMed Web of Science ®Google Scholar
• Yu X-H, Zhang D-W, Zheng X-L, et al. (2019). Cholesterol transport system: an integrated cholesterol transport model involved in atherosclerosis. Prog Lipid Res 73:65–91.
   PubMed Web of Science ®Google Scholar
• Zanganeh S, Hutter G, Spitler R, et al. (2016). Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol 11:986–94.
   PubMed Web of Science ®Google Scholar
• Zeng X, Sun J, Li S, et al. (2020). Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent. Nat Commun 11:567.
   PubMed Web of Science ®Google Scholar
• Zhang H, Lin C, Zeng C, et al. (2018). Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2. Ann Rheum Dis 77:1524–34.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang X, Ren Y, et al. (2019). An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor. Theranostics 9:3580–94.
   PubMed Web of Science ®Google Scholar
• Zhang X, Du J, Guo Z, et al. (2019). Efficient near infrared light triggered nitric oxide release nanocomposites for sensitizing mild photothermal therapy. Adv Sci 6:1801122.
   Web of Science ®Google Scholar
• Zhao H, Wang YL, Peng JR, et al. (2017). Biodegradable self-assembled micelles based on MPEG-PTMC copolymers: an ideal drug delivery system for vincristine. J Biomed Nanotechnol 13:427–36.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang Z, Xue Y, et al. (2018). Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I:C) promote melanoma regression. Theranostics 8:6307–21.
   PubMed Web of Science ®Google Scholar
• Zhao X, Ng SX, Heng BC, et al. (2013). Cytotoxicity of hydroxyapatite nanoparticles is shape and cell dependent. Arch Toxicol 87:1037–52.
   PubMed Web of Science ®Google Scholar
• Zhou F, Mei J, Yang S, et al. (2020). Modified ZIF-8 nanoparticles attenuate osteoarthritis by reprogramming the metabolic pathway of synovial macrophages. ACS Appl Mater Interfaces 12:2009–22.
   PubMed Web of Science ®Google Scholar
• Zhu X, Shen H, Yin X, et al. (2019). Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype. J Exp Clin Cancer Res 38:81.
   PubMed Web of Science ®Google Scholar